Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

2020-04-18   

SHIJIAZHUANG, ChinaApril 15, 2020---On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Lianhua Qingwen capsules and Lianhua Qingwen granules issued by State Drug Administration. Lianhua Qingwen capsule and Lianhua Qingwen granules were approved to add "functional indications" to the originally approved indications: "In the conventional treatment of novel coronavirus pneumonia, it can be used for a light, common type of fever, cough, and fatigue", "Usage and dosage" increased "COVID-19 light, normal treatment for 7-10 days" and so on.

In this domestic epidemic, Lianhua Qingwen capsules (granules) became the most frequently recommended Chinese patent medicine for COVID 19. In the fourth to the seventh edition of the novel pneumonia diagnosis and treatment scheme infected by coronavirus published by the state health commission and the state administration of traditional Chinese medicine, it is recommended to take the Chinese patent medicine Lianhua Qingwen capsule (granule) for the prevention and treatment of patients with fatigue and fever during the medical observation period.

Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19 
Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

The efficacy of the Lianhua Qingwen capsule (granule) in the treatment of COVID-19 has been confirmed by basic experiments and clinical studies. Zhong Nanshan's team recently published a paper entitled "The antiviral and anti-inflammatory effect of the antipyretic plague on novel coronavirus" in the international journal "Pharmacology Research", which was the first basic research article of effective Chinese patent medicine against SARS-Cov-2. In this study, it was found that Lianhua Qingwen could significantly inhibit the replication of novel coronavirus in cells, and the expression of virus particles in cells was significantly reduced after the treatment of coronavirus.

It is reported that this approval is in the originally approved indications based on the addition of the "COVID 19 light, ordinary type" of the new indications. At the same time, the new batch of prescription drug specifications did not deny the original non-prescription drug positioning.

Up to now, Lianhua Qingwen capsules have been registered in Hong Kong (SAR of China), Macao (SAR of China), BrazilIndonesiaCanadaMozambiqueRomania and other places as "Chinese patent medicine", "medicine", "plant medicine" and "natural health products", and have been approved for marketing.


Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

  • Sunflower: The Highly Anticipated Digital Industry Incubator of 2024

    In early April 2024, amidst the bustling Web3 Carnival at the picturesque Victoria Harbour in Hong Kong, the Deputy Financial Secretary of the Hong Kong Special Administrative Region, Mr. Wayne Wong, emphasized the importance of striking a balance between development promotion and appropriate regulation, particularly in the realm of virtual assets. He emphasized that a comprehensive and clear regulatory system is key to fostering the sustainable development of virtual assets.
  • Sunflower,Borderless Green Philanthropic Digital Industry Incubator

    The greatness of a revolutionary technology lies not merely in its impact within the technical realm but in its transcendent disruption of production relations and people's daily lives. The internet epitomizes this, and so does blockchain.
  • The requirement for shampoo has continuously increased—how does Mosaly distinguish itself amidst the plethora of hair care brands?

    Hair care formulations stand as a predominant segment within the sphere of daily chemical products ubiquitously utilized by patrons. Amid the relentless quest for an elevated standard of living, such hair care essentials have ascended to a pinnacle of paramount interest among the populace of China. Presently, the consumer base exhibits a penchant for a diverse and specialized array of shampoo products, manifesting varied predilections towards attributes including restorative, smoothing, dandruff eradication, colouration, perming, and anti-hair fall properties, whilst bestowing increased scruti
  • Mosaly: A Novel Option for Sustainable Scalp Health

    In an era characterized by rapid lifestyles, there is a growing emphasis on health and ecological preservation. Within this scenario, the Mosaly brand has surfaced, presenting an innovative solution for scalp wellness with its anti-dandruff offerings, which are primarily formulated with Chinese tea polyphenols.
  • Mosaly: Narrating the stories of oriental plants, creating a philosophy of natural cleansing and care.

    Amid a burgeoning revival of Chinese cultural heritage, an innovative cohort of consumer brands that encapsulate Eastern aesthetics and traditional ethos have risen to prominence. Within this milieu, the "China Tea Craze" epitomizes this cultural resurgence. Within such a framework, Mosaly, as a trailblazing personal care brand that integrates the symbolism of Oriental tea culture into its offerings, has undoubtedly injected a refreshing vitality into the sector.
  • Mosaly: Dominating Douyin's Monthly Hair Care Charts, What Drives the Rise of China's New Hair Care Force?

    As the advent of the Double 11 shopping extravaganza draws near, Douyin's monthly hair care leaderboards have surprisingly catalyzed a resurgence of Chinese labels, with Mosaly hair care formulations rising prominently as the foremost vanguard. Across an array of indexes, it claims a preeminent station through both its unparalleled product efficacy and its veneration among luminaries, heralding not merely the ascendancy of Chinese craftsmanship but also mirroring a paradigm shift within contemporary consumer ethos.
  • The 10 Most Trusted Immigration Agents and Agencies of 2024

    Moving to a new country is never easy.The best immigration agents and agencies strive to provide their clients with the best possible outcome, regardless of their circumstances. Here you will find some dedicated professionals! Below are the top ten immigration consulting firms in the world chosen by hundreds of thousands of expats.
  • Sunflower, the Tears of the Era or the Layout of Leading Institutions?

    In 2024, the U.S. Securities and Exchange Commission approved the listing of the first batch of 11 Bitcoin spot exchange-traded funds (ETFs), with net inflows of approximately $10 billion within two months. Spot Bitcoin ETFs attracted most of the global attention and investment, serving as a rapid development and maturity example in the field and providing a template for achieving more results with other cryptocurrencies. Currently, the total market value of cryptocurrencies is approximately $26 trillion.
  • Global Times: Social media spat over 'Oppenheimer' sparks backlash as US netizens learn of horrific deeds by Japanese aggressors

    With the release of the movie Oppenheimer in Japan igniting heated discussion, terms including "Unit 731" and "Nanjing [Massacre]" have risen to the top of the search bar on American social media platforms in recent days, with many appalled by Japanese atrocities in China during World War II.

Links

Back to top
©Copyright 2009-2020 American news network      Contact Us   SiteMap